JEROME S BRODY, M.D.
Osteopathic Medicine at Harrison Ave, Boston, MA
License number
Massachusetts 77048
Category
Osteopathic Medicine
Type
Pulmonary Disease
Address
Address
720 Harrison Ave, Boston, MA 02118
Phone
(617) 638-7480
Professional information
Dr. Jerome S Brody, Boston MA - MD (Doctor of Medicine)
Specialties:
Pulmonology
Address:
720 Harrison Ave, Boston 02118
(617) 638-7480 (Phone)
(617) 638-7480 (Phone)
Languages:
English
Hospitals:
720 Harrison Ave, Boston 02118
Boston Medical Center Corporation
1 Boston Medical Ctr Pl, Boston 02118
Boston Medical Center Corporation
1 Boston Medical Ctr Pl, Boston 02118
Education:
Medical School
University of Illinois At Chicago / College of Medicine
Graduated: 1959
University of Illinois At Chicago / College of Medicine
Graduated: 1959
Jerome S Brody, Boston MA
Specialties:
Internist
Address:
80 E Concord St, Boston, MA 02118
Education:
University of Illinois, College of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
Identification Of Novel Pathways For Drug Development For Lung Disease
US Patent:
2009018, Jul 23, 2009
Filed:
Sep 19, 2008
Appl. No.:
12/234588
Inventors:
Jerome S. Brody - Boston MA, US
Avrum Spira - Newton MA, US
Adam Gustafson - Portland OR, US
Andrea Bild - Salt Lake City UT, US
Avrum Spira - Newton MA, US
Adam Gustafson - Portland OR, US
Andrea Bild - Salt Lake City UT, US
International Classification:
A61K 31/05, C12Q 1/68, C40B 30/04, C40B 40/08, A61P 35/00
US Classification:
514734, 435 6, 506 9, 506 17
Abstract:
The invention provides the identification of oncogenic pathways activated in cytologically normal airway cells of individuals having or at risk of having lung disease, as well as specific gene expression patterns (biomarkers) associated with pathway activation. These biomarkers and pathways may provide prognostic and/or diagnostic indicators in lung disease, e.g., lung cancer. Additionally, these pathways and biomarkers may provide therapeutic targets for the treatment of lung disease, as well as markers for the assessment of treatment efficacy.